Outsourced Pharma Capabilities Update – Large Molecule

Oct 07, 2026

Biologics development and manufacturing require a CDMO partner with the right expertise, capabilities, and flexibility to support programs as they evolve.

Posted by Rentschler Biopharma Inc

Biologics development and manufacturing require a CDMO partner with the right expertise, capabilities, and flexibility to support programs as they evolve. 
 
In our latest on-demand Expert Insights video, Marine Maestracci-Roubille, our Head of Global Key Account Management, provides an overview of how we support biopharma companies throughout their development and manufacturing journey. The video highlights our large molecule capabilities, scalable bioprocessing solutions, flexible partnership approaches, and our team’s experience behind client programs. 
 
Originally presented during the Outsourced Pharma Capabilities Update on Large Molecule, the session offers a closer look at how we help clients navigate the path from clinical development to commercial manufacturing while maintaining a strong focus on reliability and quality. 
 
Watch the webinar here: https://lnkd.in/epspV-QC
 
Learn how we can help move your next breakthrough forward. 

See all Member News